The Marine Cembranoid Sarcophine Suppressed the Progression and Recurrence of the Metastatic Castration-Resistant Prostate Cancer via Downregulating EZH2-β-Catenin-Centered Oncogenic Network
Marine Drugs · 23.06.2026 · 24 (7) · 223
DOI: 10.3390/md24070223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 23.06.2026. Verfasst von Abdullah T Alhowiriny und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 7…. Hauptthemen laut MEDLINE: Diterpenes, beta Catenin, Prostatic Neoplasms, Castration-Resistant, Enhancer of Zeste Homolog 2 Protein. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saudi Arabia Cultural Mission, Louisiana Board of Regents.
Abstract (Originalsprache)
Prostate cancer (PCa) is among the highest incidence malignancies in men, with high rates of inevitable resistance development, relapse, and mortality. Castration-resistant prostate cancer (CRPC) continued to pose substantial therapeutic challenges, highlighting the urgent need for effective treatment options. This study assessed the marine cembranoid sarcophine activity against the progression and recurrence of the metastatic CRPC (mCRPC) in mouse xenograft models. Protein and phosphorylation levels were assessed by immunoblotting and mRNA expression by qPCR and RNA sequencing. The in vivo efficacy was evaluated through tumor progression over 3 weeks followed by primary tumor excision and recurrence monitoring over an 8-week course. Sarcophine significantly reduced the mCRPC CWR-R1ca tumor volume by 74.1% and suppressed the epigenetic regulators EZH2 and SMYD2; lineage plasticity factors ASCL1 and BRN2; Wnt/stemness signaling markers β-catenin and LGR6; AKT total expression and activation; and invasion-associated proteins TRPC4 and MMP2 in primary tumors. Sarcophine effectively prevented the mCRPC locoregional recurrence, as well as lung and spleen distant recurrences, and effectively reduced recurrence in other organs. Transcriptomics-RNA-Seq analysis of primary tumors identified 2697 downregulated and 3534 upregulated genes, indicating broad transcriptional reprogramming following sarcophine treatments. These findings demonstrate coordinated suppression of multi-oncogenic pathways and validate the therapeutic potential of sarcophine to control mCRPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA.
- Department of Biomedical Sciences, Discipline of Pharmacology, Edward Via College of Osteopathic Medicine, Monroe, LA 71201, USA.
ORCID-Profile: Hassan Y Ebrahim, Khalid A El Sayed
Förderung
- Saudi Arabia Cultural Mission
- Louisiana Board of Regents
Zitieren
APA
Alhowiriny, A. T., Ebrahim, H. Y., Mudhish, E. A., Dawud, D., & El Sayed, K. A. (2026). The Marine Cembranoid Sarcophine Suppressed the Progression and Recurrence of the Metastatic Castration-Resistant Prostate Cancer via Downregulating EZH2-β-Catenin-Centered Oncogenic Network. Marine Drugs, 24(7), 223. https://doi.org/10.3390/md24070223
Vancouver
Alhowiriny AT, Ebrahim HY, Mudhish EA, Dawud D, El Sayed KA. The Marine Cembranoid Sarcophine Suppressed the Progression and Recurrence of the Metastatic Castration-Resistant Prostate Cancer via Downregulating EZH2-β-Catenin-Centered Oncogenic Network. Marine Drugs. 2026;24(7):223. doi:10.3390/md24070223
BibTeX
@article{Alhowiriny2026,
author = {Alhowiriny, Abdullah T and Ebrahim, Hassan Y and Mudhish, Ethar A and Dawud, Dalal and El Sayed, Khalid A},
title = {The Marine Cembranoid Sarcophine Suppressed the Progression and Recurrence of the Metastatic Castration-Resistant Prostate Cancer via Downregulating EZH2-β-Catenin-Centered Oncogenic Network},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {7},
pages = {223},
doi = {10.3390/md24070223}
}
EUVIMED